Public, NASDAQ:VION
NASDAQ Capital Market
Vion Pharmaceuticals Inc (VION) latest rank by number of funds buying.
Date: Wed, 02 Jul 2008 17:32:31 GMT
Tags:
Vion Pharmaceuticals Inc (VION) latest rank by number of funds buying.
Mffais.com - Jul 2, 2008
Mffais.com - Jul 2, 2008
LONG BEACH ( Mffais . com ) - Vion Pharmaceuticals Inc ( VION ) is number 79 for all Therapeutics stocks ranked by number of funds buying.The total number of funds buying Vion Pharmaceuticals ...
Vion Announces Positive Data From Phase II Myelodysplastic Syndromes Trial
Date: Mon, 16 Jun 2008 17:47:38 GMT
Tags:
Vion Announces Positive Data From Phase II Myelodysplastic Syndromes Trial
RedOrbit - Jun 16, 2008
RedOrbit - Jun 16, 2008
Vion Pharmaceuticals has reported positive data from a previously conducted Phase II trial of its lead anticancer agent Cloretazine in elderly patients with acute myelogenous leukemia and high ...
Vion Pharma says Phase II trial of anticancer agent Cloretazine in elderly patients was encouraging - Update
Date: Fri, 13 Jun 2008 09:37:31 GMT
Tags:
Vion Pharma says Phase II trial of anticancer agent Cloretazine in elderly patients was encouraging - Update
RTT News - Jun 13, 2008
RTT News - Jun 13, 2008
( RTTNews ) - Vion Pharmaceuticals , Inc . ( VION : News , Chart , Quote ) said Friday that data from a previously conducted Phase II trial of its anticancer agent Cloretazine in elderly patients ...
Vion Pharma reports data from Phase II trial of anticancer agent Cloretazine - Quick Facts - RTT NewsVion Pharmaceuticals Announces Presentation of Data of Cloretazine(R) (VNP40101M) in Elderly Patients with High-Risk Myelodysplastic Syndromes at the EHA Annual Meeting
Date: Fri, 13 Jun 2008 08:43:16 GMT
Tags:
Vion Pharmaceuticals Announces Presentation of Data of Cloretazine(R) (VNP40101M) in Elderly Patients with High-Risk Myelodysplastic Syndromes at the EHA Annual Meeting
istockAnalyst.com - Jun 13, 2008
istockAnalyst.com - Jun 13, 2008
NEW HAVEN , Conn . , June 13 / PRNewswire - FirstCall / - - VION PHARMACEUTICALS , INC . ( Nasdaq : VION ) today announced that data from a previously conductedPhase II trial of its lead anticancer ...
Vion Pharmaceuticals Announces Presentation of Data of Cloretazine(R) (VNP40101M) in Elderly Patients with High-Risk Myelodysplastic Syndromes at the EHA Annual Meeting
Date: Fri, 13 Jun 2008 07:44:27 GMT
Tags:
Vion Pharmaceuticals Announces Presentation of Data of Cloretazine(R) (VNP40101M) in Elderly Patients with High-Risk Myelodysplastic Syndromes at the EHA Annual Meeting
PR Newswire (press release) - Jun 13, 2008
PR Newswire (press release) - Jun 13, 2008
NEW HAVEN , Conn . , June 13 / PRNewswire - FirstCall / - - VION PHARMACEUTICALS , INC . ( Nasdaq : VION ) today announced that data from a previously conducted Phase II trial of its lead anticancer ...
VION PHARMACEUTICALS INC Files SEC form 8-K, Other Events (EDGAR Online)
Date: Mon, 30 Jun 2008 21:01:40 Etc/GMT
Tags:
VION PHARMACEUTICALS INC Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhi (EDGAR Online)
Date: Wed, 25 Jun 2008 20:04:51 Etc/GMT
Tags:
VION PHARMACEUTICALS INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits (EDGAR Online)
Date: Tue, 17 Jun 2008 10:01:33 Etc/GMT
Tags:
Vion Pharmaceuticals Announces Presentation of Data of Cloretazine(R) (VNP40101M) in Elderly Patients with High-Risk Myelodysplastic Syndromes at the EHA Annual Meeting (PR Newswire)
Date: Fri, 13 Jun 2008 07:30:00 Etc/GMT
Tags:
VION PHARMACEUTICALS INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits (EDGAR Online)
Date: Wed, 4 Jun 2008 10:01:28 Etc/GMT
Tags: